Home > Share Market > Stocks > Torrent pharmaceuticals > Financial Statements > TORNTPHARM Key Financial Ratios

Torrent pharmaceuticals Financial Statements

Torrent pharmaceuticals Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 0.83 32.30 2.48 (12)
Op profit growth 14.50 60.90 (2) (50)
EBIT growth 15.10 32.10 (4.20) (52)
Net profit growth 22.20 51.10 (27) (46)
Profitability ratios (%)        
OPM 31.10 27.30 22.50 23.50
EBIT margin 23.50 20.60 20.70 22.10
Net profit margin 15.60 12.90 11.30 15.90
RoCE 16.30 14.50 13.70 19.60
RoNW 5.87 5.42 3.78 5.95
RoA 2.71 2.27 1.88 3.53
Per share ratios ()        
EPS 74 60.60 40.10 55.20
Dividend per share 35 32 14 14
Cash EPS 35.10 21.90 15.90 37
Book value per share 345 285 273 257
Valuation ratios        
P/E 34.40 32.60 31.10 28.10
P/CEPS 72.40 90.10 78.40 41.80
P/B 7.37 6.92 4.57 6.03
EV/EBIDTA 18.60 16.80 16.20 17.40
Payout (%)        
Dividend payout -- -- 35 25.40
Tax payout (18) (14) (27) (14)
Liquidity ratios        
Debtor days 72.30 66.70 67 74.70
Inventory days 110 94.60 107 90.90
Creditor days (137) (131) (154) (170)
Leverage ratios        
Interest coverage (5.30) (3.60) (4) (6.30)
Net debt / equity 0.72 1.06 1.21 0.37
Net debt / op. profit 1.70 2.36 4.15 1.17
Cost breakup ()        
Material costs (27) (27) (28) (31)
Employee costs (18) (18) (19) (17)
Other costs (24) (27) (31) (29)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000